Whole-body MRI quantitative biomarkers are associated significantly with treatment response in patients with newly diagnosed symptomatic multiple myeloma following bortezomib induction. (2017)
Attributed to:
Intelligent Imaging: Motion, Form and Function Across Scale
funded by
EPSRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1007/s00330-017-4907-8
PubMed Identifier: 28656463
Publication URI: http://europepmc.org/abstract/MED/28656463
Type: Journal Article/Review
Volume: 27
Parent Publication: European radiology
Issue: 12
ISSN: 0938-7994